Stuart Abelson is President & CEO of Ora, Inc., the global leader in ophthalmic research and product development. He has been a Director since 1995 and served as the Company’s Chairman from 1997 until his appointment as President in 2007.
Mr. Abelson also serves as a Trustee at the Massachusetts Eye and Ear Infirmary, was a Founder of Aciex Therapeutics and Entopica Therapeutics, and is a Board Member at Eye Therapies, LLC.
Prior to joining Ora in an operating capacity, Mr. Abelson served in various management positions at Amphenol Corporation (NYSE: APH). Mr. Abelson graduated Phi Beta Kappa and Magna Cum Laude with a Bachelor of Science degree in Neuroscience from Bates College and holds an MBA from Northwestern University’s Kellogg School of Management.